Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury
Acute kidney injury (AKI) is a condition with a poor prognosis, exacerbated by the lack of effective therapeutic options and inadequately understood underlying mechanisms. Glycosylation, a post-translational modification of proteins, is essential for maintaining protein stability and function, and i...
Saved in:
| Main Authors: | Pei Xie, Huijun Liu, Xingli Huo, Junlong Chen, Yu Li, Yu Huang, Zongning Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/17/3/145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nafamostat mesylate augments survival in rats afflicted by exertional heat stroke
by: Qingwei Lin, et al.
Published: (2025-05-01) -
Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study
by: Jiangtao Li, et al.
Published: (2025-12-01) -
Pharmacokinetic and pharmacodynamic analyses of nafamostat in ECMO patients: comparing central vein and ECMO machine samples
by: Dong Hwan Lee, et al.
Published: (2025-05-01) -
Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial
by: Hongyu Yang, et al.
Published: (2025-07-01) -
Aristolochic Acid Nephropathy: Molecular Mechanisms, Clinical Impact and Therapeutic Challenges in a Progressive Renal Disease
by: Juan José Reinoso-Calle, et al.
Published: (2025-04-01)